{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:23:02Z","timestamp":1790104982229,"version":"4.0.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.molpha.2024.100013","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:07:59Z","timestamp":1734023279000},"page":"100013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["G protein-coupled receptor\u2013targeted proteolysis-targeting chimeras in cancer therapeutics"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3418-4525","authenticated-orcid":false,"given":"Victoria R.","family":"Saca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Sakmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molpha.2024.100013_bib1","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1073\/pnas.88.24.11354","article-title":"G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity","volume":"88","author":"Allen","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2024.100013_bib2","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1002\/1873-3468.14017","article-title":"G\u00a0protein-coupled receptors and heterotrimeric G proteins as cancer drivers","volume":"594","author":"Arang","year":"2020","journal-title":"FEBS Lett"},{"key":"10.1016\/j.molpha.2024.100013_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101653","article-title":"Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs","volume":"298","author":"Bai","year":"2022","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2024.100013_bib5","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1073\/pnas.83.9.2797","article-title":"Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor","volume":"83","author":"Benovic","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.molpha.2024.100013_bib6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.chembiol.2020.04.003","article-title":"Targeted degradation of SLC transporters reveals amenability of multi-pass transmembrane proteins to ligand-induced proteolysis","volume":"27","author":"Bensimon","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/acscentsci.0c00411","article-title":"Targeted degradation of oncogenic KRAS(G12C) by VHL-recruiting PROTACs","volume":"6","author":"Bond","year":"2020","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.molpha.2024.100013_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in\u00a0vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.chembiol.2018.11.006","article-title":"Homolog-selective degradation as a strategy to probe the function of CDK6 in AML","volume":"26","author":"Brand","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib10","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1002\/anie.201307761","article-title":"Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system","volume":"53","author":"Buckley","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.molpha.2024.100013_bib11","doi-asserted-by":"crossref","first-page":"11463","DOI":"10.1002\/anie.201206231","article-title":"Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1alpha","volume":"51","author":"Buckley","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.molpha.2024.100013_bib12","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acschembio.5b00442","article-title":"HaloPROTACS: use of small molecule PROTACs to induce degradation of halotag fusion proteins","volume":"10","author":"Buckley","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib13","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1021\/ja209924v","article-title":"Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL\/HIF-1alpha interaction","volume":"134","author":"Buckley","year":"2012","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.molpha.2024.100013_bib14","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.015352","article-title":"Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling","volume":"296","author":"Ceraudo","year":"2021","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib15","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/ijc.32588","article-title":"GPER-induced signaling is essential for the survival of breast cancer stem cells","volume":"146","author":"Chan","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.molpha.2024.100013_bib16","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.1074\/jbc.M008054200","article-title":"Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors","volume":"276","author":"Chaturvedi","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib17","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.3390\/cells10123288","article-title":"An insight into GPCR and G-proteins as cancer drivers","volume":"10","author":"Chaudhary","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.molpha.2024.100013_bib18","doi-asserted-by":"crossref","first-page":"40760","DOI":"10.1074\/jbc.M111.299776","article-title":"Adaptor protein complex-2 (AP-2) and epsin-1 mediate protease-activated receptor-1 internalization via phosphorylation- and ubiquitination-dependent sorting signals","volume":"286","author":"Chen","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib19","doi-asserted-by":"crossref","first-page":"14562","DOI":"10.1021\/acs.jmedchem.0c01342","article-title":"Discovery of first-in-class potent and selective tropomyosin receptor kinase degraders","volume":"63","author":"Chen","year":"2020","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib20","doi-asserted-by":"crossref","first-page":"12559","DOI":"10.1021\/acs.jmedchem.3c01186","article-title":"Discovery of ERD-3111 as a potent and orally efficacious estrogen receptor PROTAC degrader with strong antitumor activity","volume":"66","author":"Chen","year":"2023","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nchembio.1869","article-title":"Tunable and reversible drug control of protein production via a self-excising degron","volume":"11","author":"Chung","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib22","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1210\/en.2002-0063","article-title":"Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome pathway","volume":"144","author":"Cohen","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.molpha.2024.100013_bib23","doi-asserted-by":"crossref","first-page":"27773","DOI":"10.1074\/jbc.M603369200","article-title":"Ubiquitin-dependent down-regulation of the neurokinin-1 receptor","volume":"281","author":"Cottrell","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acs.jmedchem.7b00635","article-title":"Identification and characterization of Von Hippel-Lindau-recruiting proteolysis targeting chimeras (PROTACs) of TANK-binding kinase 1","volume":"61","author":"Crew","year":"2018","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/246954","article-title":"Role of phosphorylation in the control of clathrin-mediated internalization of GPCR","volume":"2011","author":"Delom","year":"2011","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fchem.2019.00915","article-title":"Linear ubiquitin chains: cellular functions and strategies for detection and quantification","volume":"7","author":"Dittmar","year":"2019","journal-title":"Front Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/tra.12619","article-title":"Endo-lysosomal sorting of G-protein-coupled receptors by ubiquitin: Diverse pathways for G-protein-coupled receptor destruction and beyond","volume":"20","author":"Dores","year":"2019","journal-title":"Traffic"},{"key":"10.1016\/j.molpha.2024.100013_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc2069","article-title":"G-protein-coupled receptors and cancer","volume":"7","author":"Dorsam","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.molpha.2024.100013_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103138","article-title":"Technologies for the discovery of G protein-coupled receptor-targeting biologics","volume":"87","author":"Downey","year":"2024","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.molpha.2024.100013_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116489","article-title":"Discovery of novel EGFR-PROTACs capable of degradation of multiple EGFR-mutated proteins","volume":"272","author":"Du","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2017.11.009","article-title":"Subcellular organization of GPCR signaling","volume":"39","author":"Eichel","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.molpha.2024.100013_bib32","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/1078-0432.CCR-06-0860","article-title":"Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression","volume":"12","author":"Filardo","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.molpha.2024.100013_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41421-020-00237-y","article-title":"Emerging functions of branched ubiquitin chains","volume":"7","author":"French","year":"2021","journal-title":"Cell Discov"},{"key":"10.1016\/j.molpha.2024.100013_bib34","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/s41467-022-29670-1","article-title":"Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms","volume":"13","author":"Grohmann","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.molpha.2024.100013_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphar.2019.00125","article-title":"GPCR signaling regulation: the role of GRKs and arrestins","volume":"10","author":"Gurevich","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.molpha.2024.100013_bib36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new agents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.molpha.2024.100013_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuron.2010.12.001","article-title":"Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation","volume":"69","author":"He","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2024.100013_bib38","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.biotechadv.2013.08.017","article-title":"An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases","volume":"31","author":"Heng","year":"2013","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.molpha.2024.100013_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.devcel.2011.05.015","article-title":"The ESCRT pathway","volume":"21","author":"Henne","year":"2011","journal-title":"Dev Cell"},{"key":"10.1016\/j.molpha.2024.100013_bib40","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature00767","article-title":"Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL","volume":"417","author":"Hon","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2024.100013_bib41","doi-asserted-by":"crossref","first-page":"11610","DOI":"10.1074\/jbc.M513552200","article-title":"Calcium-sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin","volume":"281","author":"Huang","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202116782","article-title":"A\u00a0chemical biology toolbox targeting the intracellular binding site of CCR9: fluorescent ligands, new drug leads and PROTACs","volume":"61","author":"Huber","year":"2022","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.molpha.2024.100013_bib43","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molpha.2024.100013_bib44","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1021\/ja100691p","article-title":"Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins","volume":"132","author":"Itoh","year":"2010","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.molpha.2024.100013_bib45","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1074\/jbc.M500109200","article-title":"c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2","volume":"280","author":"Jacob","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/FJC.0000000000000482","article-title":"G\u00a0protein-coupled receptor signaling through \u03b2-arrestin-dependent mechanisms","volume":"70","author":"Jean-Charles","year":"2017","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.molpha.2024.100013_bib47","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1111\/bph.16079","article-title":"The application of targeted protein degradation technologies to G protein-coupled receptors","volume":"181","author":"Keen","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molpha.2024.100013_bib48","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1073\/pnas.1818109116","article-title":"Peptidic degron for IMiD-induced degradation of heterologous proteins","volume":"116","author":"Koduri","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2024.100013_bib49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.tibs.2022.04.003","article-title":"Assembly and function of branched ubiquitin chains","volume":"47","author":"Kolla","year":"2022","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.molpha.2024.100013_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107926","article-title":"How to target membrane proteins for degradation: bringing GPCRs into the TPD fold","volume":"300","author":"Korona","year":"2024","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib51","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.apsb.2020.01.014","article-title":"First small-molecule PROTACs for G protein-coupled receptors: inducing alpha (1A)-adrenergic receptor degradation","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.molpha.2024.100013_bib52","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.molpha.2024.100013_bib53","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/acs.molpharmaceut.1c00018","article-title":"Proteolytic targeting chimeras with specificity for plasma membrane and intracellular estrogen receptors","volume":"18","author":"Lu","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.molpha.2024.100013_bib54","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib55","doi-asserted-by":"crossref","first-page":"45509","DOI":"10.1074\/jbc.C100527200","article-title":"Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting","volume":"276","author":"Marchese","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib56","doi-asserted-by":"crossref","first-page":"11173","DOI":"10.1021\/jacs.3c00972","article-title":"Bioorthogonal tethering enhances drug fragment affinity for G protein-coupled receptors in live cells","volume":"145","author":"Mattheisen","year":"2023","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.molpha.2024.100013_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4550","article-title":"Genetic code expansion to enable site-specific bioorthogonal labeling of functional G protein-coupled receptors in live cells","volume":"32","author":"Mattheisen","year":"2023","journal-title":"Protein Sci"},{"key":"10.1016\/j.molpha.2024.100013_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk4422","article-title":"Continuous evolution of compact protein degradation tags regulated by selective molecular glues","volume":"383","author":"Mercer","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.molpha.2024.100013_bib59","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1126\/science.1073440","article-title":"Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling","volume":"296","author":"Min","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molpha.2024.100013_bib60","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/molpharm.120.000192","article-title":"Arrestin-dependent and -independent internalization of g protein-coupled receptors: methods, mechanisms, and implications on cell signaling","volume":"99","author":"Moo","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2024.100013_bib61","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ng.3549","article-title":"Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma","volume":"48","author":"Moore","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.molpha.2024.100013_bib62","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1073\/pnas.0403042101","article-title":"Seven in absentia homolog 1A mediates ubiquitination and degradation of group 1 metabotropic glutamate receptors","volume":"101","author":"Moriyoshi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2024.100013_bib63","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/emboj.2010.100","article-title":"Balanced ubiquitylation and deubiquitylation of Frizzled regulate cellular responsiveness to Wg\/Wnt","volume":"29","author":"Mukai","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.molpha.2024.100013_bib64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2024.100013_bib65","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1038\/s41467-020-18377-w","article-title":"Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules","volume":"11","author":"Nabet","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.molpha.2024.100013_bib66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","article-title":"The dTAG system for immediate and target-specific protein degradation","volume":"14","author":"Nabet","year":"2018","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellsig.2017.09.005","article-title":"GPCRs: emerging anti-cancer drug targets","volume":"41","author":"Nieto Gutierrez","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.molpha.2024.100013_bib68","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nmeth.1401","article-title":"An auxin-based degron system for the rapid depletion of proteins in nonplant cells","volume":"6","author":"Nishimura","year":"2009","journal-title":"Nat Methods"},{"key":"10.1016\/j.molpha.2024.100013_bib69","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrc3521","article-title":"The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer","volume":"13","author":"O'Hayre","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.molpha.2024.100013_bib70","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/membranes12060633","article-title":"The ESCRT machinery: remodeling, repairing, and sealing membranes","volume":"12","author":"Olmos","year":"2022","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.molpha.2024.100013_bib71","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.3390\/ijms25168984","article-title":"Inducing receptor degradation as a novel approach to target CC chemokine receptor 2 (CCR2)","volume":"25","author":"Ortiz Zacar\u00edas","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molpha.2024.100013_bib72","first-page":"2215","article-title":"Cellular resistance mechanisms to targeted protein degradation converge toward impairment of the engaged ubiquitin transfer Pathway","volume":"14","author":"Ottis","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib73","doi-asserted-by":"crossref","first-page":"12949","DOI":"10.1016\/S0021-9258(18)98787-9","article-title":"Mechanism of rhodopsin kinase activation","volume":"266","author":"Palczewski","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib74","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1124\/pharmrev.120.000082","article-title":"Post-translational modifications of G protein-coupled receptors control cellular signaling dynamics in space and time","volume":"73","author":"Patwardhan","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.molpha.2024.100013_bib75","doi-asserted-by":"crossref","first-page":"21623","DOI":"10.1074\/jbc.M116.758961","article-title":"Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4","volume":"292","author":"Peeler","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib76","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1074\/jbc.M007151200","article-title":"Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome","volume":"276","author":"Petaja-Repo","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/472720","article-title":"G\u00a0protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth","volume":"2013","author":"Petrie","year":"2013","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.molpha.2024.100013_bib78","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.biochem.67.1.653","article-title":"G\u00a0protein-coupled receptor kinases","volume":"67","author":"Pitcher","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.molpha.2024.100013_bib79","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.adm8684","article-title":"Targeting cancer with small-molecule pan-KRAS degraders","volume":"385","author":"Popow","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.molpha.2024.100013_bib80","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07961","article-title":"The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins","volume":"458","author":"Raiborg","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2024.100013_bib81","first-page":"12","article-title":"Activating mutations of TSH receptor","volume":"64","author":"Rodien","year":"2003","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.molpha.2024.100013_bib82","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1091\/mbc.4.5.511","article-title":"Identification of a novel sequence mediating regulated endocytosis of the G protein-coupled alpha-pheromone receptor in yeast","volume":"4","author":"Rohrer","year":"1993","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.molpha.2024.100013_bib83","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2024.100013_bib84","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1074\/mcp.T300009-MCP200","article-title":"Development of PROTACS to target cancer-promoting proteins for ubiquitination and degradation","volume":"2","author":"Sakamoto","year":"2003","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.molpha.2024.100013_bib85","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1016\/j.bmcl.2008.07.114","article-title":"Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics","volume":"18","author":"Schneekloth","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.molpha.2024.100013_bib86","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1021\/ja039025z","article-title":"Chemical genetic control of protein levels: selective in\u00a0vivo targeted degradation","volume":"126","author":"Schneekloth","year":"2004","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.molpha.2024.100013_bib87","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0092-8674(92)90158-9","article-title":"Immunophilin-sensitive protein phosphatase action in cell signaling pathways","volume":"70","author":"Schreiber","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.molpha.2024.100013_bib88","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1074\/jbc.M709525200","article-title":"Small molecules destabilize cIAP1 by activating auto-ubiquitylation","volume":"283","author":"Sekine","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib89","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.tips.2011.05.002","article-title":"beta-Arrestin-mediated receptor trafficking and signal transduction","volume":"32","author":"Shenoy","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.molpha.2024.100013_bib90","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1126\/science.1063866","article-title":"Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin","volume":"294","author":"Shenoy","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molpha.2024.100013_bib91","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1016\/S0021-9258(17)38026-2","article-title":"Light-dependent phosphorylation of rhodopsin. Purification and properties of rhodopsin kinase","volume":"253","author":"Shichi","year":"1978","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108532","article-title":"Functional genomics identify distinct and overlapping genes mediating resistance to different classes of heterobifunctional degraders of oncoproteins","volume":"34","author":"Shirasaki","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.molpha.2024.100013_bib93","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat0572","article-title":"Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN","volume":"362","author":"Sievers","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.molpha.2024.100013_bib94","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.chembiol.2022.08.004","article-title":"Target protein localization and its impact on PROTAC-mediated degradation","volume":"29","author":"Simpson","year":"2022","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib95","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/ijms18050923","article-title":"Regulation of G protein-coupled receptors by ubiquitination","volume":"18","author":"Skieterska","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molpha.2024.100013_bib96","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.molpha.2024.100013_bib97","doi-asserted-by":"crossref","first-page":"C84","DOI":"10.1152\/ajpcell.00015.2022","article-title":"Posttranslational modifications in GPCR internalization","volume":"323","author":"Tang","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.molpha.2024.100013_bib98","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acschembio.8b01016","article-title":"Rapid and reversible knockdown of endogenously tagged endosomal proteins via an optimized HaloPROTAC degrader","volume":"14","author":"Tovell","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib99","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jpha.2020.01.001","article-title":"The current status of anti-GPCR drugs against different cancers","volume":"10","author":"Usman","year":"2020","journal-title":"J\u00a0Pharm Anal"},{"key":"10.1016\/j.molpha.2024.100013_bib100","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.chembiol.2012.08.015","article-title":"Dissecting fragment-based lead discovery at the von Hippel-Lindau protein:hypoxia inducible factor 1alpha protein-protein interface","volume":"19","author":"Van Molle","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib101","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1080\/14756366.2022.2081164","article-title":"PROTACs for BRDs proteins in cancer therapy: a review","volume":"37","author":"Wang","year":"2022","journal-title":"J\u00a0Enzyme Inhib Med Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116166","article-title":"Annual review of PROTAC degraders as anticancer agents in 2022","volume":"267","author":"Wang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib103","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev-biochem-060614-033910","article-title":"The molecular basis of G protein-coupled receptor activation","volume":"87","author":"Weis","year":"2018","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.molpha.2024.100013_bib104","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1074\/jbc.REV119.005601","article-title":"Illuminating the Onco-GPCRome: novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy","volume":"294","author":"Wu","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib105","doi-asserted-by":"crossref","first-page":"13280","DOI":"10.1021\/acs.jmedchem.3c01264","article-title":"Discovery of ARD-1676 as a highly potent and orally efficacious AR PROTAC degrader with a broad activity against AR mutants for the treatment of AR\u00a0+ human prostate cancer","volume":"66","author":"Xiang","year":"2023","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.molpha.2024.100013_bib106","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/34201","article-title":"Activating smoothened mutations in sporadic basal-cell carcinoma","volume":"391","author":"Xie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2024.100013_bib107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-020-00435-w","article-title":"G\u00a0protein-coupled receptors: structure- and function-based drug discovery","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.molpha.2024.100013_bib108","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","article-title":"E3 ubiquitin ligases: styles, structures and functions","volume":"2","author":"Yang","year":"2021","journal-title":"Mol Biomed"},{"key":"10.1016\/j.molpha.2024.100013_bib109","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1038\/s41467-020-19532-z","article-title":"The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice","volume":"11","author":"Yesbolatova","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.molpha.2024.100013_bib110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chembiol.2019.12.006","article-title":"Exploring targeted degradation strategy for oncogenic KRAS(G12C)","volume":"27","author":"Zeng","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib111","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective small molecule induced degradation of the BET bromodomain protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.molpha.2024.100013_bib112","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1535-7163.MCT-18-1129","article-title":"Acquired resistance to BET-PROTACs (proteolysis-targeting chimeras) caused by genomic alterations in core components of E3 ligase complexes","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.molpha.2024.100013_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103803","article-title":"Pharmacologically targeting intracellular allosteric sites of GPCRs for drug discovery","volume":"28","author":"Zhang","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.molpha.2024.100013_bib114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct Target Ther"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24230194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24230194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T23:05:28Z","timestamp":1740697528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24230194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0026895X24230194"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2024.100013","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G protein-coupled receptor\u2013targeted proteolysis-targeting chimeras in cancer therapeutics","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2024.100013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100013"}}